Search Results

Showing results 501 - 510 for 1000

Three Weill Cornell Medicine Faculty Win ASCI Young Physician-Scientist Awards | Research | Weill Cornell Medicine

...Cornell Medicine Clinical & Translational Science Center, the Starr Cancer Consortium and the Polyethnic-1000...

https://research.weill.cornell.edu/about-us/news-updates/three-weill-cornell-medicine-faculty-win-asci-young-physician-scientist-awards

Partnerships | Englander Institute for Precision Medicine

...models that are available to the research community and whose goal is to generate and annotate up to 1000...

https://eipm.weill.cornell.edu/about-us/partnerships

David Rogers Health Policy Colloquium Speakers List | Weill Cornell Medicine

...Professional Affairs New York City Health and Hospitals Corporation April 12, 2000 "Science and the Next 1000...

https://weill.cornell.edu/rogers/david-rogers-health-policy-colloquium-speakers-list

DIPG: Searching for a Cure | Meyer Cancer Center

...so that we’re establishing methods for getting compounds in to the brain with an efficiency that is 1000...

https://meyercancer.weill.cornell.edu/news/2015-11-06/dipg-brain-cancer-cure

Paget, Stephen Alan

...Organizations Research Support Overview Affiliation Publications Background Contact Other Phone +1 212 606 1000...

http://vivo.med.cornell.edu/display/cwid-sap2002

Mick, Stephanie L.

...IT Times cited: 3 Early results of robotically assisted mitral valve surgery: Analysis of the first 1000...

http://vivo.med.cornell.edu/display/cwid-slmick

Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD study. | Englander Institute for Precision Medicine

...that randomized patients with mCRPC to receive cabazitaxel (25 mg/m every 3 weeks) versus abiraterone (1000...

https://eipm.weill.cornell.edu/publications/baseline-neutrophil-lymphocyte-ratio-predictive-and-prognostic-biomarker-patients

Efficacy and Safety of Cabazitaxel Versus Abiraterone or Enzalutamide in Older Patients with Metastatic Castration-resistant Prostate Cancer in the CARD Study. | Englander Institute for Precision Medicine

...cabazitaxel (25 mg/m plus prednisone and granulocyte colony-stimulating factor) versus abiraterone (1000...

https://eipm.weill.cornell.edu/publications/efficacy-and-safety-cabazitaxel-versus-abiraterone-or-enzalutamide-older-patients

Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer. | Englander Institute for Precision Medicine

...and granulocyte colony-stimulating factor) or the other androgen-signaling-targeted inhibitor (either 1000...

https://eipm.weill.cornell.edu/publications/cabazitaxel-versus-abiraterone-or-enzalutamide-metastatic-prostate-cancer

fy20_its_pois_annual_report_0.pdf

...25 integrated test scripts completed  3000+ epic released reports, 1500+ existing WCM reports and 1000...

https://its.weill.cornell.edu/sites/default/files/fy20_its_pois_annual_report_0.pdf

Showing results 501 - 510 for 1000